Germany based cannabinoid compound

Smiths falls, on and neumarkt, germany, may 2, 2019 cnw canopy growth corporation (canopy growth or the company) is pleased to announce that it has acquired german-based, bionorica se-founded c 3 cannabinoid compound company (c 3 ) in a transformative deal that will see established single cannabinoid medicines brought.

Canopy growth acquires germanys c3 cannabinoid compound.

Canopy growth corporation is pleased to announce that it has acquired the german-based, bionorica se-founded cannabinoid compound company, c3.

Germany based cannabinoid compound

C 3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in germany, austria, switzerland, and denmark.

Capital and semantic ventures.

Germany based cannabinoid compound

Canopy growth acquires germanys c3 cannabinoid compound company may 02, 2019 by communications founded by top global herbal medicine manufacturer bionorica se, c 3 is a leader in cannabinoid-based medical therapies used by european physicians to treat patients.

Chrisjan pauw snowden ventures.

Founded by top global herbal medicine manufacturer bionorica se, c3 is a leader in cannabinoid-based medical therapies used by european physicians to treat patients.

Canopy growth corporation announced on thursday that it has acquired germany based cannabinoid compound company, better known as c3, for 225.

The acquisition brings together canopy growths medical business with europes largest cannabinoid-based pharmaceuticals company.